Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration
Completed · Phase 4
Conditions studied: Retinal Degenerations
In brief
A small percentage of patients with retinal degeneration accumulate fluid in the center of their retina. Previous studies using an oral form of treatment has been successful in decreasing this fluid which improves vision. This study will test the use of a topically applied form of this treatment to the eye to reduce the amount of fluid and improve or preserve vision.
Key facts
- Study ID
- NCT00716586
- Run by
- University of Illinois at Chicago
- People needed
- 44
- Starts
- 2005-10-01
- Expected to finish
- 2017-11-17
- Last updated by the study team
- 2021-10-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Presence of cystic macular fluid on OCT testing
You may not qualify if…
- Allergic reaction to sulpha containing compounds
- Intolerance to dorzolamide (Trusopt)
Where it is running
- University of Illinois Medical Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.